Senzime shares (OTCQX: SNZZF) are now trading on the OTCQX Market in the US. This is in addition to the Nasdaq Main Market listing in Stockholm.
Our CEO Phillip Siberg joined Steve Darling from Proactive at the OTC studios in New York City to shed light on the innovative solutions offered by Senzime, aimed at significantly enhancing patient safety during and post-surgery through the power of advanced algorithms.
